AngioDynamics (STU:UG2) Cyclically Adjusted Book per Share: €11.56 (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:UG2 AngioDynamics Inc STU:UG2
64 GF Score
Price €11.80
GF Value €8.32
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is AngioDynamics Cyclically Adjusted Book per Share?

AngioDynamics STU:UG2 -3.28% 64 Cyclically Adjusted Book per Share is €11.56 as of May. 2026. GuruFocus rates STU:UG2 with a GF Score™ of 64/100 and a GF Value™ of €8.32 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

AngioDynamics's adjusted book value per share for the three months ended in May. 2026 was €3.507. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €11.56 for the trailing ten years ended in May. 2026.

During the past 12 months, AngioDynamics's average Cyclically Adjusted Book Growth Rate was -7.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -6.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -3.90% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -1.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of AngioDynamics was 8.40% per year. The lowest was -6.40% per year. And the median was 0.40% per year.

As of today (2026-07-18), AngioDynamics's current stock price is €11.80. AngioDynamics's Cyclically Adjusted Book per Share for the quarter that ended in May. 2026 was €11.56. AngioDynamics's Cyclically Adjusted PB Ratio of today is 1.02.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of AngioDynamics was 1.89. The lowest was 0.34. And the median was 0.95.


AngioDynamics  (STU:UG2) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

AngioDynamics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=11.80/11.56
=1.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of AngioDynamics was 1.89. The lowest was 0.34. And the median was 0.95.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


AngioDynamics Cyclically Adjusted Book per Share Related Terms


AngioDynamics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for AngioDynamics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AngioDynamics Cyclically Adjusted Book per Share Chart

AngioDynamics Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.47 15.17 14.41 12.29 11.56

AngioDynamics Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.29 11.84 11.87 11.40 11.56

STU:UG2 vs NNNN, OSUR, UTMD: Cyclically Adjusted Book per Share Comparison

For the Medical Instruments & Supplies subindustry, AngioDynamics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AngioDynamics Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AngioDynamics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where AngioDynamics's Cyclically Adjusted PB Ratio falls into.


STU:UG2
64GF Score
AngioDynamics Inc STU:UG2
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AngioDynamics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, AngioDynamics's adjusted Book Value per Share data for the three months ended in May. 2026 was:

Adj_Book= Book Value per Share /CPI of May. 2026 (Change)*Current CPI (May. 2026)
=3.507/335.1230*335.1230
=3.507

Current CPI (May. 2026) = 335.1230.

AngioDynamics Quarterly Data

Book Value per Share CPI Adj_Book
201608 12.448 240.849 17.320
201611 13.290 241.353 18.453
201702 13.576 243.603 18.676
201705 12.652 244.733 17.325
201708 11.846 245.519 16.169
201711 11.966 246.669 16.257
201802 11.730 248.991 15.788
201805 12.332 251.588 16.427
201808 12.586 252.146 16.728
201811 12.894 252.038 17.145
201902 12.987 252.776 17.218
201905 14.613 256.092 19.123
201908 14.532 256.558 18.982
201911 14.621 257.208 19.050
202002 14.707 258.678 19.053
202005 10.954 256.394 14.318
202008 10.034 259.918 12.937
202011 10.027 260.229 12.913
202102 9.770 263.014 12.449
202105 9.382 269.195 11.680
202108 9.497 273.567 11.634
202111 9.691 277.948 11.684
202202 9.669 283.716 11.421
202205 10.252 292.296 11.754
202208 10.352 296.171 11.713
202211 10.131 297.711 11.404
202302 9.378 300.840 10.447
202305 8.786 304.127 9.681
202308 9.754 307.026 10.647
202311 9.217 307.051 10.060
202402 5.015 310.326 5.416
202405 4.703 314.069 5.018
202408 4.348 314.796 4.629
202411 4.308 315.493 4.576
202502 4.355 319.082 4.574
202505 3.959 321.465 4.127
202508 3.707 323.976 3.835
202511 3.669 324.122 3.794
202602 3.519 326.785 3.609
202605 3.507 335.123 3.507

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €11.56 mean?
AngioDynamics (STU:UG2) has a Cyclically Adjusted Book per Share of €11.56 as of May. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on AngioDynamics and its competitors.
Is AngioDynamics' Cyclically Adjusted Book per Share too high?
AngioDynamics' current Cyclically Adjusted Book per Share is €11.56. Overall, AngioDynamics has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AngioDynamics' Cyclically Adjusted Book per Share compare to NNNN and OSUR?
AngioDynamics' Cyclically Adjusted Book per Share of €11.56 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on AngioDynamics and its competitors. AngioDynamics's current Cyclically Adjusted Book per Share is €11.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AngioDynamics stock overvalued right now?
Based on GuruFocus' analysis, AngioDynamics (STU:UG2) is currently considered Significantly Overvalued. The stock's GF Value™ is €8.32, compared to a current price of €11.80 — trading 41.8% above its estimated fair value. The current Cyclically Adjusted Book per Share is €11.56. AngioDynamics' overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For AngioDynamics (STU:UG2), the current Cyclically Adjusted Book per Share is €11.56 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AngioDynamics (STU:UG2) Overvalued in 2026?

Based on GuruFocus' analysis, AngioDynamics stock appears to be overvalued. The current stock price of €11.80 is trading 41.8% above its estimated GF Value™ of €8.32. GuruFocus considers AngioDynamics to be Significantly Overvalued.

Key valuation signals for STU:UG2:

  • Cyclically Adjusted Book per Share: €11.56
  • GF Value™: €8.32 vs. price of €11.80 (41.8% above fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the STU:UG2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AngioDynamics Business Description

Other Exchanges ANGO:USA
Address 14 Plaza Drive, Latham, NY, USA, 12110
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
64GF Score

Get the complete analysis for STU:UG2

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.80
Price
€8.32
GF Value